FGFBP1 and cerebrovascular disorder: Taken together, our results indicate for the first time, to the best of our knowledge, that miR-4432 specifically targets the 3′UTR of FGFBP1, thereby representing a novel potential strategy against hypertension, cerebrovascular disease, and other disorders characterized by endothelial dysfunction.